Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Heat on Corplex Donepezil TDS Delivery
NCT03438604Phase 1Completed
- Sponsor
- Corium
- Start
- Feb 2018
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of donepezil in Alzheimer's disease (AD) (3 arms), sponsored by Corium. Primary endpoints: Maximum Plasma Concentration at 6 weeks and Area Under the Curve at 6 weeks. Started Feb 2018; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03438604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03438604.